Details

Published: 05 July 2016

Insulin developers from Sverdlovsk will receive 183 million roubles to expand their production. Almost 200 million roubles will be invested in the insulin production in the Urals. The money will be allocated by the Industry Development Fund. The loan will be directed to the expansion of the first biopharmaceutical import-substituting production of genetically engineered insulin.

Read more ...

Details

Published: 30 December 2014

Triazavirin has been recommended for use by the Ministry of Health of the Russian Federation.

Read more ...

Details

Published: 29 December 2014

Ural Triazavirin has finally been released. This antiviral drug developed by Sverdlovsk scientists has come pharmacies today. This is such a long-awaited event that the Ural medicine has been sold out briskly.

Read more ...

Details

Published: 22 September 2014

Already this season, the Ural Triazavirin will fight against flu and cold. The antiviral drug produced in Novouralsk will soon appear in Russian pharmacies. The Federal Ministry of Health issued a permission to produce the drug.

Read more ...

Details

Published: 22 September 2014

"The Ministry of Health of the Russian Federation issued a permission to produce the Triazavirin antiviral drug developed in the Urals," said Oleg Chupakhin, Chief Researcher at the Institute of Organic Synthesis, the Ural Branch of the Russian Academy of Sciences, and head of the drug development team.

Read more ...